A phase Ib/II clinical trial on intratumoral autologous myeloid dendritic cell therapy in combination with AS01B adjuvant and immune-checkpoint blockade

Tijtgat, J. (Speaker)

Activity: Talk or presentationTalk or presentation at a conference

Period19 May 2022
Event titleKnowledge For Growth
Event typeConference
LocationGent, Belgium
Degree of RecognitionNational